Penumbra
PEN
#1783
Rank
NZ$15.80 B
Marketcap
$411.69
Share price
0.54%
Change (1 day)
8.26%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Net assets

Net assets on the balance sheet as of September 2024 : NZ$1.89 Billion

According to Penumbra's latest financial reports the company has NZ$1.89 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Penumbra - Net assets on balance sheet (from 2014 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$NZ$1.86 B18.5%
2022-12-31$NZ$1.57 B12.65%
2021-12-31$NZ$1.39 B58%
2020-12-31$NZ$0.88 B22.59%
2019-12-31$NZ$0.72 B14.5%
2018-12-31$NZ$0.62 B11.7%
2017-12-31$NZ$0.56 B46.52%
2016-12-31$NZ$0.38 B13.26%
2015-12-31$NZ$0.33 B-2251.9%
2014-12-31$-NZ$15.79 Million60.93%
2013-12-31$-NZ$9.82 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NZ$0.74 B-60.63%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.26 B 19.84%๐Ÿ‡บ๐Ÿ‡ธ USA